View clinical trials related to Dengue Virus.
Filter by:To evaluate effect of previous flavivirus exposure on the safety and immunogenicity of the ChimeriVax™ dengue tetravalent vaccine Primary Objectives: - To describe the safety of one injection of ChimeriVax™ dengue tetravalent vaccine. - To describe the immune response against dengue before and after one injection of ChimeriVax™ dengue tetravalent vaccine
This study used 3 different formulations of tetravalent CYD dengue vaccine. The primary objective of the study was to evaluate the neutralizing antibody response after 2 doses of two different formulations of tetravalent dengue vaccine administered at Month 0 and Month 6. The secondary objectives were: - To evaluate the safety of the 3 formulations of tetravalent CYD dengue vaccine. - To describe the neutralizing antibody responses to each of the 3 vaccine formulations. - To describe vaccine viremia after the first and second dose of each of the 3 vaccine formulations in a subset of participants.